Urologie pro praxi 4/2016

Effects of a hexane extract of saw palmetto (Serenoa repens, Permixon® 160 mg, available as Capistan® in Czech Republic) on inflammatory biomarkers in treating symptoms associated with benign prostatic hyperplasia

Chronic prostatic inflammation (CPI) can cause symptomatic or complicated benign prostatic hyperplasia (BPH). Based on available data, Capistan, a hexane extract of Serenoa repens (HESr), has anti-inflammatory properties. The aim of the present study was to provide a new insight into the anti-inflammatory effects of HESr by investigating the effect on CPI biomarkers in men with lower urinary tract symptoms (LUTS) due to BPH, while using non-invasive methods and exploring the association between the level of biomarkers and clinical symptoms.

Keywords: benign prostatic hyperplasia, chronic prostatic inflammation, hexane extract of Serenoa repens, lower urinary tract symptoms, Capistan.